-+ 0.00%
-+ 0.00%
-+ 0.00%

Korro Bio Q2 EPS $(1.07) Beats $(1.31) Estimate

Benzinga·08/06/2026 11:28:00
Listen to the news
Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1.31) by 18.32 percent. This is a 60.95 percent increase over losses of $(2.74) per share from the same period last year.